Supply of Omeprazole Extended-Release Capsules
Contract Overview
Solicitation details, issuing organization, response deadlines, documents, and interested companies for this government contract opportunity.
AI Contract Overview
The contract entails the manufacture and delivery of Omeprazole Extended-Release Capsules under strict compliance with FDA current Good Manufacturing Practices to ensure product quality and safety. The capsules must adhere to Department of Defense labeling standards specified by the Defense Logistics Agency and include traceable shipping documentation to support accountability and logistical precision. The end destination is a U.S. Navy construction site, requiring precise coordination for timely and secure delivery in alignment with military supply chain protocols. This subcontract falls under the NAICS code 325412, indicating classification within pharmaceutical and medicine manufacturing, and is issued under the broader authority of the Department of Defense. All deliverables must meet federal requirements for pharmaceuticals supplied to military medical operations, with full documentation and compliance maintained throughout production, packaging, and distribution.
General Info
Agency
NAICS
Place of Performance
Not specifiedSet-Aside
Documents
This scope was carved out of SPE2D9-26-F-7395.
The full solicitation package (2 documents), including the RFP, is on the prime solicitation, not on this scope.
OMEPRAZOLE EXTENDED-RELEASE CAPSULES
AI Contract Breakdown
Uniform Contract FormatNo contract breakdown available.
Cannot generate Contract Breakdown because no documents were found from this contract's source.
Timeline
Organization & Contact Information
Full Description
Similar Contracts
Same NAICS industry code
More opportunities from Department Of Defense → Defense Logistics Agency
Same awarding agency
